The results showed that tPA-treated stroke patients were 32 percent more likely to show minimum or no disability at 3 months (odds ratio 1.7, CI 1.2–2.6, NNT 8, NNH 16, and ARR 12%), compared to patients who did not get tPA. The gene discussed is PLAT; the disease is stroke disorder.